Use these resources and tools for your AF clinic.
AF affects more than 33 million people globally, and more than 5 million in the US.1 There are several potential benefits to indicated patients receiving catheter ablation. Catheter ablation is a safe and effective alternative after AADs.2-3 View the webinar below to learn more about treating AF patients from the points of view of Valley Health System Cardiologist, Dr. Kedar Sankholkar, and the EP Lab Director at Valley Health, Dr. Suneet Mittal.
Jointly Addressing the Growing AF Challenge
This interactive webinar broadcast features a dialogue between a cardiologist and an electrophysiologist surrounding the growing AF challenge. They share their expertise on the current treatment options to address AF and discuss how to optimize outcomes.
Mozaffarian, et al. "Heart disease and stroke statistics—2016 update." Circulation 133.4 (2016): e38-e360.
Packer DL, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713-23.
Wilber DJ, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010 Jan 27;303(4):333-40.